TME Pharma announces receipt of agreements in principle to extend certain bond agreements. Berlin, Germany, November 17, 2025, 08.00am CET -TME Pharma N.V ... TME Pharma emphasizes that its primary goal remains to unlock the value of its biotech assets.
With that, I'm pleased to turn the call over to Cussion, Executive Chairman of TME... The success of these shows illustrates TME's strength and impact in broadening artists' fan bases, especially.
TME PHARMA ... TME Pharma reaffirms its commitment to advancing its biotech assets, with discussions continuing in parallel with potential partners. Berlin, Germany, November 05, 2025, 08.00am CET - TME Pharma N.V ... TME Pharma N.V ... About TME Pharma.
TME Pharma N.V ...Forward looking statements reflect only TME Pharma's current views and assumptions regarding future events, many of which are by nature inherently uncertain and beyond TME Pharma N.V.'s control ... TME Pharma N.V., Amsterdam, Netherlands.
) TME Pharma publishes its semi annual results and half-year report. Berlin, Germany, October 30, 2025, 21.00am CET - TME Pharma N.V ... The first half of the year was marked by TME Pharma's reorganization to a lower-cost outsourced staffing model.
In the days following the conclusion of the TMEFallSummit, on October 3, 2025, the U.S ... "We were honored to participate in the TME ... for low-risk breast cancer in the days following the TME Summit.".
TME PHARMA ... TME Pharma N.V ... About TME Pharma. TME Pharma is a clinical-stage biotechnology company specializing in the development of novel therapies for cancer and eye diseases ... TME Pharma N.V ... TME PHARMA N.V ... TME PHARMA.